Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels.

Adolescent vaping of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids increased significantly from 2021 to 2023.

(Alliance News) - Ananda Pharma PLC on Tuesday said the first subject has been dosed in the phase 1 pharmacokinetic study for its lead cannabidiol drug candidate, MRX1. Ananda is a London-based ...